Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of initial levothyroxine treatment in women with subclinical hypothyroidism and pregnancy outcomes
ChiCTR1900022494Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levothyroxine sodium in hypothyroidism (4 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Adverse pregnancy outcome. Started Apr 2019; status: recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on ChiCTR1900022494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022494.